Wasdell Announce Ireland Facility
28 November 2017
It is with great pleasure that we can now formally announce that we will be building a brand new pharmaceutical facility in Dundalk, Ireland. The facility will be a purpose built, 70,000 sq. ft, self-contained site located at the IDA Dundalk Science and Technology Park, Mullagharlin from which we will continue to service our customers situated in the pharmaceutical and healthcare sectors.
Phase one of the build will occupy a 2.88 hectare site and represent an investment in excess of €30M and will create 300 jobs. Wasdell also hold the land options to expand the site further with an additional 2.68 hectares.
The facility will offer QC import testing, a variety of current and novel packaging technologies as well as storage and distribution. The site will be operational by Q4 2018 and will incorporate serialisation technology in addition to bespoke customer manufacturing solutions.
The site will be our first outside of the UK and will allow us to continue servicing our customers’ requirements for import and release testing, the primary and secondary packing of our customers drug product as well as the distribution of such products into Europe as well as internationally. The building of the new facility will not only assist with our strategy of growth over the coming years but also provide our solution to a “hard” Brexit if this becomes a reality.
Martin Tedham, Group Managing Director stated “we are delighted to have found such an ideal location for our new facility and a special thanks must be given to the Irish Government, the IDA as well as Louth County Council for their support in making our new site a reality. This is an exciting time for our business and will allow us to not only increase our capacity but also extend our operational footprint and the services we are able to offer our client base”